Satoshi Minoshima

Active 1989–2025

118
Papers
34,840
Citations
87
h-index
113
i10-index

Citations

Citations per year for Satoshi Minoshima1962: 1 citations1983: 1 citations1986: 1 citations1987: 1 citations1989: 3 citations1990: 10 citations1991: 5 citations1992: 10 citations1993: 12 citations1994: 24 citations1995: 52 citations1996: 107 citations1997: 167 citations1998: 206 citations1999: 260 citations2000: 395 citations2001: 422 citations2002: 405 citations2003: 399 citations2004: 371 citations2005: 417 citations2006: 354 citations2007: 454 citations2008: 433 citations2009: 437 citations2010: 450 citations2011: 427 citations2012: 387 citations2013: 388 citations2014: 378 citations2015: 304 citations2016: 341 citations2017: 348 citations2018: 272 citations2019: 728 citations2020: 707 citations2021: 654 citations2022: 512 citations2023: 387 citations2024: 523 citations2025: 338 citations2026: 18 citations1963–1982: no citations, so these years are not shown1984–1985: no citations, so these years are not shown1988: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,689 citing papers, 31.1% of this breakdownUnited Kingdom: 1,469 citing papers, 9.7% of this breakdownGermany: 1,013 citing papers, 6.7% of this breakdownItaly: 680 citing papers, 4.5% of this breakdownChina: 656 citing papers, 4.4% of this breakdownCanada: 623 citing papers, 4.1% of this breakdownJapan: 617 citing papers, 4.1% of this breakdownFrance: 512 citing papers, 3.4% of this breakdownNetherlands: 489 citing papers, 3.2% of this breakdownAustralia: 437 citing papers, 2.9% of this breakdownSweden: 427 citing papers, 2.8% of this breakdownSpain: 421 citing papers, 2.8% of this breakdown
0%31.1%Other 20.3%

Fields

  • Medicine58.6%
  • Neuroscience24.9%
  • Biochemistry, Genetics and Molecular Biology7.4%
  • Psychology3.4%
  • Computer Science1.7%
  • Nursing0.8%
  • Other3.2%

Topics

  • Alzheimer's disease research and treatments7.9%
  • Dementia and Cognitive Impairment Research7.7%
  • Parkinson's Disease Mechanisms and Treatments4.1%
  • Functional Brain Connectivity Studies4.1%
  • Neural and Behavioral Psychology Studies2.8%
  • Memory and Neural Mechanisms2.1%
  • Other71.3%

Coauthors

All papers

Open in search
  1. Diagnosis and management of dementia with Lewy bodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenji Kosaka, V.M.Y. Lee, Andrew J. Lees, Irene Litvan, Elisabet Londos, Oscar L. López, Satoshi Minoshima, Y Mizuno, J. A. Molina, Elizabeta B. Mukaetova‐Ladinska, Florence Pasquier, R. H. Perry, Jörg B. Schulz, John Q. Trojanowski, Masahito Yamada - Neurology 2005 cited by 5,057

  2. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander Drzezga - The Lancet Neurology 2020 cited by 531

  3. Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation

    Authors: , , - Brain 2003 cited by 955

  4. Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

    Authors: , , , , , , , , , , , , - Alzheimer s & Dementia 2013 cited by 596

  5. 18F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies

    Authors: , , , , - Journal of Nuclear Medicine 2022 cited by 164

  6. Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes

    Authors: , , , , , - Archives of Neurology 2010 cited by 635

  7. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease

    Authors: , , , , , - Annals of Neurology 1997 cited by 1,795

  8. SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0

    Authors: , , , , , , , , , , , , - Journal of Nuclear Medicine 2016 cited by 258

  9. Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup

    Authors: , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2025 cited by 94

  10. Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias

    Authors: , , , , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2008 cited by 723

  11. Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E

    Authors: , , , , , , , - New England Journal of Medicine 1996 cited by 1,371

  12. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease

    Authors: , , , , , , , , , , - Brain 2007 cited by 606

  13. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

    Authors: , , , , - 1995 cited by 1,008

  14. Brain PET in Suspected Dementia: Patterns of Altered FDG Metabolism

    Authors: , , , , - Radiographics 2014 cited by 253

  15. Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association

    Authors: , , , , , , , , , , , , - Journal of Nuclear Medicine 2013 cited by 322

  16. Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders

    Authors: , , , - Seminars in Nuclear Medicine 2021 cited by 87

  17. Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection

    Authors: , , , , , , , , , , , , , , - The Lancet Neurology 2015 cited by 273

  18. Neuroimaging, Behavioral, and Psychological Sequelae of Repetitive Combined Blast/Impact Mild Traumatic Brain Injury in Iraq and Afghanistan War Veterans

    Authors: , , , , , , , , , , , , - Journal of Neurotrauma 2013 cited by 216

  19. Cloning and chromosomal mapping of the human nonfunctional gene for L-gulono-gamma-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man.

    Authors: , , , , - Journal of Biological Chemistry 1994 cited by 509

  20. Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study

    Authors: , , , , , , - Journal of Nuclear Medicine 2011 cited by 212

  21. Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood–Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease

    Authors: , , , , , , , , , , , , , - Journal of Nuclear Medicine 2014 cited by 189

  22. The DNA sequence of human chromosome 21

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kazuhiko Kawasaki, Shuichi Asakawa, Ai Shintani, Takashi Sasaki, Kentaro Nagamine, Susumu Mitsuyama, Stylianos E. Antonarakis, Satoshi Minoshima, Nobutaka Shimizu, Gabriele Nordsiek, Klaus Hornischer, P. Brandt, Maren Scharfe, Oliver Schön, A. Desario, Julia Reichelt, Gerhard Kauer, Helmut Blöcker, Juliane Ramser, Amy Beck, Sven Klages, Steffen Hennig, L. Rießelmann, Emilie Dagand, Thomas Haaf, S. Wehrmeyer, Katja Borzym, Katheleen Gardiner, Dean Nižetić, Fiona Francis, Hans Lehrach, Richard Reinhardt, Marie‐Laure Yaspo - Nature 2000 cited by 1,479

  23. Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature

    Authors: , , , , - Journal of Nuclear Medicine 2011 cited by 284

  24. The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification

    Authors: , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2022 cited by 23